HLA-DRB 1 alleles and the susceptibility of Iranian patients with breast cancer

Pathology and Oncology Research

Volumn 7, Issue 1, 2001, Pages 39-41

  Ghaderi, A ^a   Talei, A ^a   Gharesi Fard, B ^a   Farjadian, S H ^a   Amirzargar, A ^a   Vasei, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast cancer; HLA DRB 1; PCR SSP

Indexed keywords

HLA DR ANTIGEN; DNA; HLA-DRB1 ANTIGEN;

ALLELE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HLA SYSTEM; HUMAN; HUMAN TISSUE; IRAN; POLYMERASE CHAIN REACTION; ADULT; BREAST TUMOR; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; RISK FACTOR;

ADULT; ALLELES; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; IRAN; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0034743462     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032603     Document Type: Article

References (17)

1. An overview of breast cancer incidence and mortality
2. Population genetics of BRCA1 and BRCA2
3. A strong candidate for the breast and ovarian cancer susceptibility
4. Expression and susceptibility of modulation by interferones of HLA-class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance
5. HLA-class II antigen expression in human papilomavirus-associated cervical cancer
6. HLA expression in human hepatocellular carcinoma
7. HLA antigens in colorectal tumours-low expression of HLA class I antigens in mucinous colorectal carcinomas
8. Analysis of HLA-DRB1-related alleles in Japanese patients with lung cancer-relationship to genetic susceptibility and resistance to lung cancer
9. The isolation of high molecular weight DNA from whole organisms or large tissue masses
10. A simple sahing out procedure for extracting DNA from human nucleated cells
11. HLA-DR typing by PCR amplification with PCR-SSP in two hours
12. Serological and molecular study on the HLA phenotype of female breast cancer patients
13. The role of CD4+ T cells responses in antitumor immunity
14. MHC class II-transfected tumor cells directly present antigen to tumor specific CD4+ T lymphocytes
15. ClassII-transformed tumor cells directly present endogenous antigen to CD4+ T cells in vitro and are APCs for tumor-encoded antigen in vivo
16. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: Histopathologically similar but biologically distinct entities
17. CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion